If you have been reading about acetylated peptide and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-02-26. Where a claim depends on a specific study, the study is described rather than over-claimed.
The peptide is generated in cells by cleavage of prothymosin alpha, a larger acidic protein encoded by the PTMA gene. Prothymosin alpha is expressed in many tissues, not only in the thymus, and its functions include nuclear roles in chromatin-related processes. The 28-residue fragment corresponds to the N-terminal portion of that precursor. How the cleavage occurs and how the fragment's concentration is regulated remain open questions; circulating amounts are small and difficult to measure reliably with routine assays.
Thymosin alpha 1 is a short peptide first isolated from bovine thymus tissue in the early 1970s during fractionation work aimed at identifying factors that influence T cell development. It belongs to a family of acidic thymic peptides, and the original preparations contained several components that were later separated by chromatography. The compound is now produced synthetically rather than extracted from tissue, which removes batch variability tied to animal sourcing. Researchers describe it as an immunomodulatory peptide because laboratory studies show effects on several cell types of the innate and adaptive immune systems.
Most published studies on thymosin alpha-1 report changes in immune measurements rather than clinical outcomes, and findings differ across designs and populations. Whether the peptide signals through one defined receptor or through several less specific interactions remains an open question. Its reported circulation half-life of a few hours complicates comparison of dosing schedules across trials. Mechanistic claims are frequently drawn from isolated cell cultures, and how far those results extend to whole organisms is unresolved.
Thymosin alpha-1 is a synthetic peptide of 28 amino acids whose sequence matches the amino-terminal region of prothymosin alpha. The chain is acetylated at its first residue and contains one disulfide bridge between two cysteine residues, which folds the molecule into a compact loop. Its molecular formula, C129H215N33O55, corresponds to a monoisotopic mass of roughly 3,106 daltons. Material used in laboratories is made by solid-phase synthesis rather than isolated from animal tissue.
Early work on thymic extracts in the 1960s described a heat-stable acidic fraction containing many polypeptides. Separation of that mixture yielded individual components, and thymosin alpha-1 was named as one of them on the basis of assays for T-cell activity. The first preparations came from calf thymus, while subsequent research and clinical material has been chemically synthesized. Nomenclature in older papers is inconsistent, and the same peptide sometimes appears under different designations, which complicates literature searches.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Acetylated peptide | N-terminal acetyl group blocks aminopeptidase attack |
| Residue count | 28 amino acids | Matches the N-terminus of prothymosin alpha |
| Molecular mass | About 3,108 Da | Value for the free, unmodified peptide |
| Isoelectric point | Approximately 4.2 | Acidic; net negative charge at neutral pH |
| Encoding gene | PTMA | Human gene for the precursor protein |
Immune signaling studies link thymosin alpha 1 to Toll-like receptor pathways, particularly TLR2 and TLR9, on dendritic cells and other antigen-presenting cells. Activation of these receptors promotes maturation of T cells and increases natural killer cell activity. The peptide shifts cytokine output toward a T helper 1 profile, raising interferon gamma and interleukin 2 while modulating interleukin 10. Whether these effects translate into clinical benefit for any specific disease remains a subject of debate. Reported outcomes vary across trials and populations.
Thymosin alpha 1 is approved as a medicine in several countries, including Italy and China, for indications such as chronic hepatitis B and as an immune adjuvant. It is not approved by the United States Food and Drug Administration as a therapeutic product. In research settings the peptide appears in studies of sepsis, vaccine response, and oncology support, often with mixed or inconclusive results. The evidence base is uneven, and reviews note that many trials were small. Regulatory status therefore differs widely between jurisdictions.
Thymosin alpha 1 is a synthetic 28-amino-acid peptide first isolated in 1966 from thymosin fraction 5, a bovine thymus extract. Its chain begins with an acetylated serine residue and ends with asparagine. The native peptide carries a molecular mass near 3,108 daltons. Researchers classify it as an immunomodulatory agent rather than a hormone with a single endocrine target. Early work framed it as a thymus-derived factor that supports T-cell maturation. The synthetic form used in research and clinical products matches the natural sequence.
Clinical interest has centered on chronic viral hepatitis, on immune restoration in various conditions, and on use as an adjuvant intended to improve responses to vaccines. Trials have reported mixed results, and regulatory status differs sharply between countries; in some places it is a prescription product, while elsewhere it is sold without an approved therapeutic indication. Because published studies vary widely in design, population, and endpoints, comparisons across them are difficult and no single conclusion covers the whole literature.
Thymosin alpha 1 is a short peptide of 28 amino acid residues that derives from the amino terminal region of a larger precursor protein known as prothymosin alpha. The peptide carries an acetyl group on its first residue and contains no disulfide bonds or carbohydrate chains. Its sequence is highly conserved across mammalian species, which is one reason laboratories treat it as a molecule with a defined and reproducible structure rather than a variable tissue extract. The name follows an early naming convention for thymus-derived fractions and does not imply that the peptide acts as a hormone in the classical endocrine sense.
Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Results across trials have been mixed, and several studies were small or conducted under differing protocols. Regulatory status varies by country, and the compound is not approved in every jurisdiction where it is studied. Evidence for any single indication should be read with attention to sample size and endpoint choice.
Thymosin alpha-1 is a 28-residue peptide first isolated from thymus tissue in the 1970s. It corresponds to the N-terminal portion of thymosin beta-4, from which it is cleaved in vivo. The peptide carries an acetyl group at its N-terminus, a modification that affects its charge and stability. Synthetic material produced by solid-phase peptide synthesis is chemically identical to the natural fragment and is the form used in research and clinical studies.
== Publications == 1922: Researches on the insect metamorphosis. Doctoral Thesis on the histology of metamorphosis of the Chalcid wasp, Nasonia. 1922: On the arrangement of the striations of voluntary muscle fibres in double spirals. 1932: "The Innervation of the Striated Musculature in Python", The Australian Journal of Experimental Biology and Medical Science, Vol.9, No.1, (January 1932), pp. 191-201. 1938: Memoirs: The Embryonic Development of Calandra oryzae. (with Florence V. Murray) see Sitophilus oryzae the rice weevil. 1942: The ‘Dorsal Organ’ of the Embryo of Campodea. 1945: Memoirs: The Post-Embryonic Development of Hanseniella agilis (Symphyla). 1947: The development and affinities of the Pauropoda, based on a study of Pauropus silvaticus. 1955: The Path of the Slow Contractile Wave in Arthropod Muscle Fibre. (with E. Matthaei) Photographic records are consistent with the hypothesis that the slow waves move along the helicoid.
==== Sharp criteria ==== The Sharp criteria require at least four major criteria, as well as anti-U1-RNP antibody titer of at least 1:4000, or two major criteria from criteria 1, 2, and 3, and two minor criteria, plus anti-U1-RNP antibody titer of at least 1:1000. The Sharp criteria also excludes anyone with a positive anti-Sm antibody. It has a sensitivity of 42% and a specificity of 87.7%. Major criteria:
water A polar inorganic compound with the chemical formula H2O that is a tasteless, odorless, and generally colorless liquid at standard temperature and pressure, though it also occurs naturally as a solid and a gas at the Earth's surface. It is the most abundant substance on Earth and therefore an integral component of virtually all chemical and biological systems. Water is often described as the "universal solvent" for its inherent ability to dissolve many substances.
The United States has a higher percentage of low-income workers than almost any other developed country, largely because of a weak collective bargaining system and lack of government support for at-risk workers.
3D printing could be a precise tool in designing pills to house several drugs, because the control over the structure of pills that 3D Printing provides could in theory help make better pills for drugs that have specific release times. The technology allows the pills to transport to the targeted area and degrade safely in the body. Besides, 3D printing might become more useful in medical implants. An example includes a surgical team that has designed a tracheal splint made by 3D printing to improve the respiration of a patient. This example shows the potential of 3D printing, which allows physicians to develop new implant and instrument designs easily. Overall, in the future of medicine, 3D printing will likely be crucial as it can be used in surgical planning, artificial and prosthetic devices, drugs, medical implants, and more.
Sources: en.wikipedia.org
== Side effects == Adverse effects of hydromorphone are similar to those of other potent opioid analgesics such as morphine and heroin. The major hazards of hydromorphone include dose-related respiratory depression, urinary retention, bronchospasm, and sometimes, circulatory depression. More common side effects include lightheadedness, dizziness, nystagmus, sedation, itching, constipation, nausea, vomiting, headache, perspiration, and hallucinations. These symptoms are common in ambulatory patients and in those not experiencing severe pain. Simultaneous use of hydromorphone with other opioids, muscle relaxants, tranquilizers, sedatives, and general anesthetics may significantly depress respiration, progressing to coma or death. Taking benzodiazepines (e.g., diazepam) in conjunction with hydromorphone may increase side effects such as dizziness and difficulty concentrating. If simultaneous use of these drugs is required, dose adjustment may be made. A particular problem that may occur with hydromorphone is accidental administration in place of morphine due to a mix-up between the similar names, either at the time the prescription is written or when the drug is dispensed. This has led to several deaths and calls for hydromorphone to be distributed in distinctly different packaging from morphine to avoid confusion. Massive overdoses are rarely observed in opioid-tolerant individuals, but when they occur, they may lead to circulatory system collapse.
=== Juvenile idiopathic arthritis === Adalimumab has been shown to reduce the signs and symptoms of moderate to severe polyarticular juvenile idiopathic arthritis in children aged four years and older.
=== Policy on Scouting America === In November 2025, Hegseth in a draft memo proposed eliminating the promotion for Eagle Scouts who join the Army and other services due to the lack of "masculine values" and "promoting gender confusion." He also threatened to cut all support from the Department of Defense to Scouting America. The proposal in the draft memo would eliminate support to the National Jamboree as well as ban military bases from hosting or sponsoring scout units. He claimed that the organization was attacking "boy-friendly" spaces by allowing girls to join the organization in 2018. Military families and retired military have criticized the possible actions by Hegseth, stating it will harm military dependent children who depend on the organization as a stabilizing force. Other critics stated that this proposal would harm the military, as 20 percent of military academy students are former scouts and a number of scouts go directly into the military due to the partnership. Navy Secretary John Phelan wrote a memo of his own, stating, "Passive support to Scouting America through access to military installations and educational opportunities aboard said installations serve as a crucial recruiting and community engagement tool for the [Navy]". On February 27, 2026, Scouting America announced that they would immediately drop the Citizenship in the Society merit badge, will create a military service merit badge and waive registration fees for dependent children of active duty military, National Guard and reserve families.
=== Library of the School of Medicine === The School of Medicine at the University of Patras have an independent library to be used from the student's community of the School. The library provides a reading room (150 seats), a copy machine with charge of use and computers. Users may also borrow books from the library as long as they have the library card.
Sources: en.wikipedia.org
== History == Golden Harvest InfoTech Limited was established in 2000. It is a software export-oriented company. Golden Harvest started manufacturing frozen food in 2006. Golden Harvest founded Taher Ahmed Choudhury Charitable Hospital in 2006 in Bhadeshwar Union, Golapganj Upazila, Sylhet District. Golden Harvest Developers Limited was established in 2009. In January 2011, Golden Harvest Agro was given an A grade by the British Retail Consortium. Golden Harvest Group established Golden Harvest Foods Limited in 2012 to manufacture snacks such as chips and chanachur. It signed an agreement with Nippon Express to launch a joint venture company in Bangladesh. In October 2012, Golden Harvest Agro Industries received permission for their IPO on the Dhaka Stock Exchange. In 2014, Golden Harvest launched a cold chain network with funding from the United States Agency for International Development (USAID). It also received support from the Cold Chain Bangladesh Alliance. Golden Harvest is a sponsor of Dhaka Art Summit, of which Rajeeb Samdani is the founder. In March 2018, Golden Harvest signed an agreement with Jubilant FoodWorks to launch Domino's Pizza in Bangladesh. The first branch was opened in Dhanmondi on 15 March 2019 under a joint venture company called Jubilant Golden Harvest Limited. During the COVID-19 pandemic in Bangladesh, sales of frozen food increased for Golden Harvest. Frozen Paratha and bread sales increased while frozen snacks such as samosa, sausages and ice cream declined dramatically.
Highly refractory woods These woods are slow and difficult to dry if the final product is to be free from defects, particularly cracks and splits. Examples are heavy structural timbers with high density such as ironbark (Eucalyptus paniculata), blackbutt (E. pillularis), southern blue gum (E. globulus) and brush box (Lophostemon cofertus). They require considerable protection and care against rapid drying conditions for the best results. Moderately refractory woods These timbers show a moderate tendency to crack and split during seasoning. They can be seasoned free from defects with moderately rapid drying conditions (i.e. a maximum dry-bulb temperature of 85 °C can be used). Examples are Sydney blue gum (E. saligna) and other timbers of medium density, which are potentially suitable for furniture. Non-refractory woods These woods can be rapidly seasoned to be free from defects even by applying high temperatures (dry-bulb temperatures of more than 100 °C) in industrial kilns. If not dried rapidly, they may develop discolouration (blue stain) and mould on the surface. Examples are softwoods and low density timbers such as Pinus radiata.
The 1988 US presidential elections lent new urgency to the negotiations, which had recently stalled after six consecutive rounds of talks in Brazzaville. Angola and Cuba had gambled heavily on a victory for Michael Dukakis and the Democratic Party during the US elections, hoping that this would spell the end of US aid to UNITA and a harder line on South Africa. At the time of the Geneva Protocol, dos Santos had commented that "if the Democrats had won the elections, there would be a readjustment in US policy, particularly on Southern Africa". The election of Republican candidate George H. W. Bush had the effect of persuading the Angolan and Cuban delegations to be more flexible. Crocker reiterated on several occasions that a new US administration meant changes in personnel and basic policy review, and pressed them not to waste months of effort. Three days after the US election results were released, the parties reconvened in Geneva and within the week had agreed to a phased Cuban withdrawal over the course of twenty seven months. In exchange, South Africa pledged to begin bestowing independence on South West Africa by 1 November 1989. On 13 December 1988, South Africa, Angola, and Cuba signed the Brazzaville Protocol, which affirmed their commitment to these conditions and set up a Joint Military Monitoring Commission (JMMC) to supervise the disengagement in Angola. The JMMC was to include Soviet and US observers. All hostilities between the belligerents, including PLAN, were to formally cease by 1 April 1989.
passive transport The movement of a solute across a membrane by traveling down an electrochemical or concentration gradient, using only the energy stored in the gradient and not any energy from external sources. Contrast active transport.
requirement for the safety factor). In a tokamak, instabilities also arise from resistive MHD. For instance, tearing modes are instabilities that arise within the framework of non-ideal MHD. This is an active field of research because these instabilities are the starting point for disruptions.
Sources: en.wikipedia.org
Thymosin fraction 5 is a mixture of many peptides obtained from thymus tissue, while thymosin alpha 1 is a single defined 28-residue molecule. The two names appear together in older literature because the purified peptide was first obtained from that mixture.
The precursor, prothymosin alpha, is encoded by the PTMA gene in humans. The 28-residue peptide corresponds to the N-terminal segment released from that larger protein.
It is produced as a fragment of prothymosin alpha and is present in many tissues. Circulating concentrations are low, which makes routine measurement difficult.
Its sequence corresponds to the amino-terminal portion of prothymosin alpha, a larger protein present in many cell types. The isolated 28-residue peptide is a fragment of that protein rather than a separately encoded molecule, and laboratory material is produced by synthesis.